Brown Capital Management LLC Has $68.41 Million Position in Enfusion, Inc. (NYSE:ENFN)

Brown Capital Management LLC decreased its holdings in shares of Enfusion, Inc. (NYSE:ENFN - Free Report) by 15.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,208,596 shares of the company's stock after selling 1,365,923 shares during the period. Enfusion comprises about 1.5% of Brown Capital Management LLC's portfolio, making the stock its 25th largest holding. Brown Capital Management LLC owned approximately 5.61% of Enfusion worth $68,410,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. Quest Partners LLC bought a new stake in Enfusion during the third quarter worth approximately $308,000. Gladius Capital Management LP grew its holdings in shares of Enfusion by 160.5% in the 3rd quarter. Gladius Capital Management LP now owns 69,694 shares of the company's stock worth $661,000 after acquiring an additional 42,939 shares during the last quarter. Royce & Associates LP raised its holdings in Enfusion by 35.4% during the 3rd quarter. Royce & Associates LP now owns 99,715 shares of the company's stock worth $946,000 after buying an additional 26,045 shares during the period. Impax Asset Management Group plc raised its holdings in shares of Enfusion by 25.4% during the third quarter. Impax Asset Management Group plc now owns 676,948 shares of the company's stock valued at $6,424,000 after acquiring an additional 136,948 shares during the period. Finally, Versor Investments LP purchased a new stake in shares of Enfusion in the 3rd quarter valued at approximately $501,000. Institutional investors own 81.05% of the company's stock.

Enfusion Trading Up 1.2 %

NYSE ENFN traded up $0.12 during trading on Thursday, hitting $10.01. 333,731 shares of the company traded hands, compared to its average volume of 382,595. The company has a market capitalization of $1.29 billion, a P/E ratio of 247.31, a PEG ratio of 3.60 and a beta of 0.93. The business has a fifty day simple moving average of $9.10 and a 200 day simple moving average of $8.86. Enfusion, Inc. has a 12 month low of $7.52 and a 12 month high of $10.45.

Enfusion Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.